Six Maryland companies are set to pitch to a panel of investors during two competitions at a health technology conference in early September in Boston.
Maryland companies are finalists in the First Coast Innovation Challenge and were selected as competitors in the RESI Innovation Challenge competitions at the Redefining Early Stage Investments conference.
Companies affiliated with technology hubs are eligible to compete in the First Coast Innovation Challenge. Three of the eight finalists for this competition are from Maryland:
Abilis Life Sciences Inc., a company working on bladder cancer diagnostics, and Theradaptive Inc., a regenerative medicine company, are both based at the Frederick Innovative Technology Center incubator. Avidea Technologies Inc., which engineers vaccines for cancer treatment and infectious disease prevention, is based at Johns Hopkins’ FastForward technology incubator in Baltimore, and entered the competition through BioHealth Innovation Inc. in Rockville.
The RESI Innovation Challenge is for companies generally in their Series A or B financing rounds. Three Maryland companies are among the 30 selected to pitch:
Otomagnetics Inc., based in North Bethesda, is working on magnetically-assisted drug delivery.
Diagnostic Biochips Inc. of Glen Burnie, is engineering bioelectronic implants.
Sonavex Inc. of Baltimore, is developing surgical imaging technology.